ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 638624 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 638624; 2) Community: the network communities that were significantly associated with the response to NSC 638624; 3) Molecule: the relationships between components within communities and NSC 638624; 4) MDR: the compounds that were significantly associated with the NSC 638624.

NSC Compound Enrichment Correlation
NSC 746035 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone 0.0209467683758286 0.10272483
NSC 750335 (E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0209467683758286 -0.12620636
NSC 750743 (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0209467683758286 0.26348302
NSC 752461 Null 0.0209467683758286 0.31828246
NSC 92915 ANTINEOPLASTIC-92915 0.0209467683758286 0.19335467
NSC 106246 Null 0.022188614181866 0.20974692
NSC 132230 Null 0.022188614181866 0.21730772
NSC 169434 component of Monistat cream 0.022188614181866 0.16276476
NSC 264077 Phosphonium, (2-bromoethyl)triphenyl-, bromide 0.022188614181866 0.11272354
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.022188614181866 0.0074583025
Total:76  Current:35    [First] [Prev] [Next] [Last]